SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as community members discuss the company's groundbreaking on its first Aurora powerhouse in Idaho and a Wedbush price target hike, fueling debate about the company's valuation and future potential in the clean energy sector. While some see a promising long-term play with policy tailwinds, others express concerns about the pre-revenue status, potential dilution, and insider selling, creating a battleground between bulls and bears.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending amid speculation of a potential buyout or partnership, possibly involving TikTok or OpenAI, driving significant volume. The community is buzzing about a possible short squeeze, new AI AR smart glasses and the potential impact of any deal on Snap's ad business. Chatter suggests the stock may be undervalued, with some eyeing a gap fill and others anticipating a major move this week.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

$PFE is trending due to the announced acquisition of Metsera in a deal to expand Pfizer's presence in the obesity drug market, sparking community discussion around the deal's value and potential impact. Some investors believe Pfizer overpaid, while others anticipate further acquisitions in the obesity and related sectors, with speculation around potential targets like $VKTX and $ALT. The acquisition reflects a broader interest in obesity treatments, with communities weighing the competitive landscape and potential for new drugs.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending due to increased attention on its AI cloud capacity and revenue targets, with recent news highlighting the company's doubled GPU fleet and upgraded AI revenue guidance. Community members are actively discussing the stock's potential for further gains and comparing it to peers in the AI infrastructure and data center space. Bullish sentiment surrounds IREN's strategic positioning within the growing AI sector and its potential for significant revenue growth.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending due to news of Mike Alfred joining the board, sparking excitement about his potential to accelerate growth and shape the company's strategy in digital assets and AI. The community is actively discussing how this appointment could enhance Bakkt's position in the fintech and crypto space. Bullish sentiment is also fueled by speculation around potential acquisitions and the company's moves in the crypto sector.

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

MBX Biosciences Inc.

MBX Biosciences is trending due to positive Phase 2 trial results for its hypoparathyroidism drug, canvuparatide, showing a significant responder rate and prompting discussions of potential Phase 3 advancement. The community is actively discussing the possibility of a short squeeze and the stock's potential to break past key resistance levels. This positive data and potential advancement come as the company is also working on an obesity candidate, contributing to overall investor excitement.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP.X is trending amidst a broader crypto dip, sparking debates about market manipulation and future price predictions. While some community members are expressing frustration and calling for lower prices to buy more, others remain optimistic, citing upcoming ETFs and Ripple's involvement in talks between the U.S. and U.K. regarding crypto cooperation as potential catalysts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid a critique amplified by Martin Shkreli questioning its technology's viability, sparking debate about its quantum advantage claims and long-term prospects. The community is weighing the criticism against positive developments like institutional buying and potential government support for quantum computing, resulting in volatile trading and discussions around short squeezes and future catalysts.

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.

Semler Scientific Inc

Semler Scientific is trending due to discussions around a proposed merger with Strive, Inc. ($ASST) in an all-stock transaction that values SMLR at a significant premium, and community members are weighing the potential benefits and risks. Some traders are focusing on a lawsuit the company is facing, while others are eyeing the Bitcoin treasury aspect of the deal, especially as it relates to the valuation of both companies.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending as traders discuss the impact of the company receiving FDA 510(k) clearance for its RNA sequencing diagnostic device, Tempus xR IVD. Community members are highlighting the potential for a short squeeze and anticipating a climb to new all-time highs, with some suggesting a target price of $100. Bullish sentiment is fueled by the clearance's potential to support drug development programs and the company's growing presence in the AI-driven healthcare sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


8888Bxyz

Nhà cái 8888B